Gynecologic Cancer Survivors Movement to Wellness

November 2019 Vol 10, No 11
Robin Atkinson, RN, BSN, OCN

Background: Studies demonstrate that many gynecological (Gyn) cancer patients are reluctant to exercise during and after treatment due to fatigue and general weakness. This is the most distressing symptom affecting their quality of life.1-3 A local assessment of this population in our community practice reflected the same mindset with obesity and fatigue continuing into the survivorship phase of care. The YMCA LIVESTRONG program has shown positive outcomes in addressing these symptoms with their 12-week program.1 A program from this model was designed for Gyn survivors, with 2 of the sessions devoted to better nutrition and healthy food choices. The program was taught by a board-certified specialist in oncology nutrition and creator of cancerdi to address, motivate, and empower women to make positive lifestyle changes. Any Gyn cancer patient could participate in this free class with the approval of their physician.

Objectives: The goals were to improve balance, increase walking distance, leg and chest presses for strength, and enhance flexibility by stretching and reaching exercises. Also, a sense of well-being with a decrease in fatigue was projected in this population.

Methods: Participant interviews and pre- and postmeasures of endurance, balance, strength, and flexibility at the YMCA by LIVESTRONG trainers. The testing shadowed the pre- and post-LIVESTRONG guidelines for measurement.4 Individual reporting for the overall effectiveness of the program was captured by a posttest questionnaire.

Results: Fifty percent completed the posttest and showed improvement in endurance, balance, strength, and flexibility. A sense of increased well-being with a decrease in fatigue was reported by all who completed the class. The remaining 50% partially completed the program due to a fall, low blood counts, general sickness, or physical issues. The partial completers did not complete a posttest.

Conclusion: Individual participants reported enjoyment with other ladies while exercising. This program showed positive outcomes in addressing general weakness and fatigue by demonstrating improvements in endurance, balance, strength, and flexibility. The pilot program offered encouragement and motivation to keep moving and exercise at a comfortable pace.

In the future, the class will be lengthened to a 90-minute session as program participants suggested to allow them more time to exercise. The next class will start earlier in the year to avoid the vacation issues. Also, due to absences related to side effects, the next class will target posttreatment survivors only. Recruitment was suboptimal, and we need to explore means to increase interest in the program.


  1. Musanti R, ChaoYY, Collins K. Fitness and quality of life outcomes of cancer survivor participants in a community exercise program. J Adv Pract. 2019;10:24-37.
  2. Maqbali MA, Hughes C, Dunwoody L, et al. Exercise interventions to manage fatigue in women with gynecologic cancer: a systematic review. Oncology Nursing Forum. 2019;46:71-82.
  3. Cramp F, Byron-Daniel, J. Exercise for the management of cancer‐related fatigue in adults. Cochrane Database Syst Rev. 2012;1:CD006145.
  4. Schumacher MM. McNiel P. The impact of Livestrong at the YMCA for cancer survivors. Oncol Nurs Forum. 2018;45:717-725.
Related Articles
Personalized Cancer Navigation Is a Phone Call Away
Karen Costello, MSS, LSW
February 2022 Vol 13, No 2
6-Month LHRH Formulations Are a Good Choice During the COVID-19 Pandemic and Beyond
Tina DeNofrio, RN, BSN, OCN, Stuart N. Atkinson, MB, ChB, Deborah M. Boldt-Houle, PhD
November 2021 Vol 12, No 11
Prostate cancer (PCa) patients treated with injectable androgen deprivation therapy (ADT) are particularly vulnerable during a pandemic because they may not be able to self-administer treatment and may be required to visit a clinic/hospital for injections.
A Virtual Prostate Cancer Clinic for Follow-Up Care: A Digital Health Platform Creates Efficient Navigation and Care Coordination Benefiting Survivors, Provider, and the Healthcare System
Richard N. Boyajian, Ashleigh M. Kowtoniuk, PA, APRN-NP, Krystle R. Boyajian, Mark J. Mackin, MBA, RT(T)
November 2021 Vol 12, No 11
Prostate cancer is the most common male malignancy. In 2021, the United States will see an estimated 248,530 new cases, 34,130 deaths, and more than 3 million survivors.
Last modified: May 10, 2021

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
    Profession or Role
    Primary Specialty or Disease State

    Please enter your mailing address.

    Address Line 2
    Zip Code